DOGZ Dogness (International) Corp
Miscellaneous Manufacturing Industries · Nasdaq · SEC CIK 1707303 · Fiscal year ends 06/30
Financial factors as of 2026-06-30 (FY2026), by fiscal year; growth vs the previous fiscal year
Growth
TTM revenue YoY-23.3%
TTM net income YoY-441.6%
TTM EPS YoY-307.9%
Revenue 3-yr CAGR110.6%
Net income 3-yr CAGR—
Margins
Gross margin16.0%
Operating margin-181.4%
Net margin-173.9%
FCF margin-49.7%
EBITDA margin-164.3%
Returns
ROE-32.0%
ROA-26.2%
ROIC (approx.)-29.3%
Asset turnover0.15x
Leverage & solvency
Liabilities / assets20.3%
Debt / equity0.00x
Current ratio1.12x
Interest coverage282.34x
Cash quality & payout
Operating cash flow / net income0.08x
Accruals ratio-24.1%
Payout ratio—
Capex / revenue35.5%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20262026-06-30 | FY20252025-06-30 |
|---|---|---|
| Income statement | ||
| Revenue | $15.88M | $20.71M |
| Cost of revenue | $13.34M | $15.68M |
| Gross profit | $2.55M | $5.03M |
| R&D expense | $956,862 | $1.12M |
| SG&A expense | $6.53M | $8.38M |
| Operating income | -$28.81M | -$6.79M |
| Interest expense | -$102,039 | -$80,503 |
| Pretax income | -$28.82M | -$6.18M |
| Income tax | -$1.19M | -$1.08M |
| Net income | -$27.63M | -$5.10M |
| EBITDA | -$26.09M | -$4.01M |
| EPS (basic) | -1.55 | -0.38 |
| EPS (diluted) | -1.55 | -0.38 |
| Weighted avg. shares (diluted) | 17.81M | 13.41M |
| Balance sheet | ||
| Cash & equivalents | $4.49M | $12.83M |
| Receivables | $1.67M | $1.31M |
| Inventory | $1.67M | $2.72M |
| Current assets | $8.50M | $17.05M |
| PP&E, net | $58.31M | $58.26M |
| Intangibles | $579,891 | $1.75M |
| Total assets | $94.12M | $116.85M |
| Current liabilities | $7.60M | $6.11M |
| Total liabilities | $19.10M | $19.09M |
| Shareholders' equity | $75.02M | $97.75M |
| Shares outstanding | — | 14.23M |
| Cash flow statement | ||
| Operating cash flow | -$2.25M | $1.13M |
| Capital expenditure | $5.64M | $1.59M |
| Free cash flow | -$7.90M | -$453,070 |
| Investing cash flow | -$5.64M | $312,252 |
| Financing cash flow | -$576,662 | $4.40M |
| Depreciation & amortization | $2.72M | $2.78M |
| Stock-based compensation | — | $183,127 |
Free plan shows the latest 2 periods; Pro shows all 11 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.